Leadership Overview
Medpace has 4 executives leading key functions including clinical research strategy, information technology, revenue generation, and corporate operations.
Focused on accelerating medical breakthroughs, Medpace delivers comprehensive clinical development services to global life sciences organizations, ensuring rigorous regulatory compliance and scientific excellence throughout the entire drug development lifecycle.
Focused on accelerating medical breakthroughs, Medpace delivers comprehensive clinical development services to global life sciences organizations, ensuring rigorous regulatory compliance and scientific excellence throughout the entire drug development lifecycle.
Leadership Roles at Medpace
Jesse Geiger - President
Jesse Geiger, the President at Medpace, directs the overall corporate strategy and operational execution for the global clinical research organization. Geiger oversees the alignment of scientific research capabilities with the commercial objectives of pharmaceutical and biotechnology partners. By managing the executive leadership team, the President ensures consistent delivery of high-quality clinical development services from early-stage research through regulatory approval. This leadership role involves driving organizational growth through the expansion of service offerings and the strengthening of global market presence. Jesse Geiger fosters a culture of scientific excellence, ensuring that all clinical trials meet the highest standards of safety and efficacy. Through the oversight of large-scale operational initiatives, the President optimizes resource utilization and enhances the efficiency of the entire clinical development pipeline. Ultimately, Geiger guides the long-term vision of the company, ensuring sustained success in the competitive landscape of global life sciences research.
Brandon Ebken - Chief Information Officer
Brandon Ebken, the Chief Information Officer at Medpace, architects the digital infrastructure supporting global clinical research operations. Ebken directs the development of secure data management systems, ensuring compliance with international privacy regulations and industry standards for clinical trial data. By integrating advanced analytics into the research workflow, the Chief Information Officer enhances the speed and accuracy of trial reporting for pharmaceutical manufacturers. This leadership role involves overseeing cybersecurity initiatives to protect sensitive patient information across all regional operations. Brandon Ebken drives the digital transformation of clinical development processes, enabling seamless collaboration between internal research teams and external partners. Through the deployment of scalable cloud solutions, the Chief Information Officer supports the expansion of global research capabilities. Ultimately, Ebken ensures that technological assets remain aligned with the evolving needs of the life sciences industry, providing a stable foundation for complex medical research projects.
Anna Oliverio - Project Coordinator & Chief Revenue Officer
Anna Oliverio, the Project Coordinator & Chief Revenue Officer at Medpace, drives the financial growth strategy while managing complex clinical trial logistics. Oliverio directs revenue optimization efforts by aligning service offerings with the specific needs of biotechnology and medical device clients. By overseeing the coordination of multi-site clinical trials, the Project Coordinator & Chief Revenue Officer ensures that project timelines remain synchronized with budgetary targets. This leadership role involves negotiating high-value contracts and fostering long-term partnerships with global pharmaceutical manufacturers. Anna Oliverio monitors market trends to identify new opportunities for service expansion, ensuring the organization maintains a competitive edge in the clinical research sector. Through the integration of project management best practices, the Project Coordinator & Chief Revenue Officer improves operational margins and resource allocation. Ultimately, Oliverio secures the financial stability required to support ongoing investment in scientific research and development across all international markets.
Carolyn Glashagen - Managing Director
Carolyn Glashagen, the Managing Director at Medpace, oversees complex clinical development programs for global biotechnology and pharmaceutical clients. Glashagen directs the strategic execution of early-stage research initiatives, ensuring alignment with stringent regulatory standards across international markets. By managing cross-functional teams, the Managing Director optimizes trial design and patient recruitment strategies to accelerate time-to-market for critical medical therapies. This leadership role involves constant collaboration with scientific experts to refine operational workflows and enhance data integrity throughout the clinical trial process. Carolyn Glashagen maintains a focus on operational efficiency, driving high-quality outcomes for medical device organizations. Through the implementation of standardized protocols, the Managing Director secures consistent performance across diverse therapeutic areas. Ultimately, Glashagen fosters a culture of scientific rigor, supporting the overarching mission of delivering innovative healthcare solutions to patients worldwide while maintaining robust financial health for the organization.
Explore Leadership Teams in Business Services
PAREXEL International Corporation, a biopharmaceutical outsourcing services company, provides clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting Services (PC), and PAREXEL Informatics (PI). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management, and biostatistical analysis, epidemiology and health economics/outcomes research, clinical supply and drug logistics, pharmacovigilance, commercialization, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PC segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance; and market and product development, and targeted communications services to support product launch, as well as offers solutions to address client issues associated with product development, registration, and commercialization. The PI segment provides information technology solutions comprising ClinPhone randomization and trial supply management solutions, medical imaging services, IMPACT clinical trial management systems, LIQUENT InSight regulatory information management software and professional services, DataLabs electronic data capture systems, Web-based portals, systems integration services, electronic patient reported outcomes, and patient diary applications, as well as centralized assessment services for patient technology solutions. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham,...
Company Leadership AS
Certerra is a technology-enabled testing, inspection, and certification services company that supports new product development, engineering, construction, and infrastructure asset management. The company provides specialized services designed to help clients bring products to market efficiently, verify compliance with applicable codes and standards, manage engineering requirements, and maintain quality throughout project delivery. Its testing, inspection, and certification capabilities support organizations seeking to ensure that products, materials, systems, and construction projects meet required technical, safety, quality, and regulatory standards.
Company Leadership
DC
PS
Mars Veterinary Health is a global veterinary health organization dedicated to providing high-quality preventive, general, specialty, and emergency care across 3,000 clinics worldwide. With a team of nearly 70,000 passionate associates, including over 12,000 veterinarians, they focus on improving the health and wellbeing of pets and supporting veterinary professionals. The company emphasizes innovation and scientific breakthroughs, leveraging advanced technologies and extensive data to enhance veterinary care. Their mission is to create a better world for pets and the people who care for them.
Company Leadership
TT
LP
TM
ECRI is an independent, nonprofit organization dedicated to advancing the safety, quality, and cost-effectiveness of healthcare across all settings. With a strong focus on patient safety, evidence-based practices, and technology decision support, ECRI is widely recognized and trusted by healthcare leaders and government agencies around the world. For over fifty years, ECRI has earned its reputation through integrity, rigorous research, and a steadfast commitment to independence, supported by strict conflict-of-interest policies. It remains the only organization globally to perform independent evaluations of medical devices, with testing laboratories located in both North America and the Asia Pacific region. ECRI is designated as an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality and is a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services. In 2020, the Institute for Safe Medication Practices (ISMP) officially became an affiliate of ECRI.
Company Leadership
DK
JN
Frequently Asked Questions Regarding Medpace Top Executives and Leadership Team
Unlock more people and company data
